Related Experiment Video
Updated: May 2, 2026
14:53
A Microfluidic-based Electrochemical Biochip for Label-free DNA Hybridization Analysis
Published on: September 10, 2014
16.4K
Kinetics of DNA binding with chloroquine phosphate using capacitive sensing method.
Fan Yin1, Manli Guo, Shouzhuo Yao
1State Key Laboratory of Chemo/Biological Sensing and Chemometrics, Hunan University, Changsha 410082, China.
Biosensors & Bioelectronics
|November 15, 2003
Summary
Capacitive sensing reveals distinct binding stages between DNA and chloroquine phosphate. Double-strand DNA (dsDNA) shows two binding phases, unlike single-strand DNA (ssDNA), indicating specific intercalation mechanisms.
Area of Science:
- * Electrochemistry
- * Biophysics
- * Molecular Biology
Background:
- * DNA-drug interactions are crucial for understanding therapeutic mechanisms.
- * Chloroquine phosphate is an antimalarial drug with known DNA-binding properties.
- * Electrochemical methods offer sensitive detection of molecular binding events.
Purpose of the Study:
- * To investigate the binding kinetics of chloroquine phosphate with DNA using capacitive sensing.
- * To differentiate the binding mechanisms between double-strand DNA (dsDNA) and single-strand DNA (ssDNA).
Main Methods:
- * Immobilization of DNA onto a gold electrode surface modified with thioglycolic acid.
- * Application of capacitive sensing to monitor real-time DNA-drug interactions.
- * Quartz Crystal Impedance (QCI) spectroscopy to analyze binding characteristics.
Main Results:
- * Capacitive sensing data revealed two distinct kinetic stages for dsDNA- ‐chloroquine binding, consistent with QCI findings.
- * A single kinetic stage was observed for single-strand DNA (ssDNA) binding with chloroquine.
- * Kinetic parameters were determined, estimating rate constants for electrostatic attraction and intercalation.
Conclusions:
- * The study elucidates the multi-stage binding process of chloroquine with dsDNA, involving electrostatic attraction and intercalation.
- * Capacitive sensing provides a sensitive platform for characterizing DNA-drug interactions with distinct kinetic profiles.
- * Differences in binding kinetics between dsDNA and ssDNA highlight the structural specificity of chloroquine binding.
